Combined high cut-off of CXCL8, VEGF and PTX-3 values was present only in 11% (7/63) of CRC patients, but this subgroup efficiently identified 71.4% (5/7) of relapsing cases. The gene discussed is CXCL8; the disease is colorectal carcinoma.